Showing results (631-640 of 981) with videos related to

Sort By:
Pageof 99
Cardiovascular Therapeutics|October 8, 2014
Different effects of fenofibrate on metabolic and cardiovascular risk factors in mixed dyslipidemic women with normal thyroid function and subclinical hypothyroidismRobert Krysiak, Wojciech Gilowski, Witold Szkrobka, et al.
Cardiovascular Therapeutics|June 19, 2013
Epidemiology of CYP3A4-mediated clopidogrel drug-drug interactions and their clinical consequencesTuire Tirkkonen, Pekka Heikkilä, Tero Vahlberg, et al.
Cardiovascular Therapeutics|October 22, 2013
Effects of neutral endopeptidase (neprilysin) inhibition on the response to other vasoactive peptides in small human resistance arteries: studies with thiorphan and omapatrilatJonathan R Dalzell, Alison Seed, Colin Berry, et al.
Cardiovascular Therapeutics|October 11, 2013
Influence of feeding and intracoronary dose on insulin-mediated relative akt phosphorylation in the porcine myocardiumGrete Slettom, Anne Kristine Jonassen, Lars Breivik, et al.
Cardiovascular Therapeutics|October 12, 2013
Geometry of the randomized evidence for treatments of pulmonary hypertensionAdriano R Tonelli, Joe Zein, John P A Ioannidis
Cardiovascular Therapeutics|July 12, 2013
Safety, tolerability, and efficacy of overnight switching from sildenafil to tadalafil in patients with pulmonary arterial hypertensionShelley Shapiro, Glenna Traiger, Wendy Hill, et al.
Cardiovascular Therapeutics|July 20, 2013
Effect of simvastatin on plasma homocysteine levels and its modification by MTHFR C677T polymorphism in Chinese patients with primary hyperlipidemiaShanqun Jiang, Qianru Chen, Scott A Venners, et al.
Cardiovascular Therapeutics|December 16, 2015
Potential Roles of Humanin on Apoptosis in the HeartSavitree T Charununtakorn, Krekwit Shinlapawittayatorn, Siriporn C Chattipakorn, et al.
Cardiovascular Therapeutics|December 30, 2014
Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL studyMohapradeep Mohan, Stephen McSwiggan, Fatima Baig, et al.
Cardiovascular Therapeutics|August 24, 2017
The vasorelaxant effect of antidiabetic drug nateglinide via activation of voltage-dependent K+ channels in aortic smooth muscleHongliang Li, Hye Won Kim, Sung Eun Shin, et al.
Pageof 99